Cycle Pharmaceuticals and Inceptua Group expand the Free Goods Programme for patients with Hereditary Tyrosinemia Type 1 (HT-1) and Alkaptonuria (AKU) to include Morocco and Egypt.
January 9, 2026
January 9, 2026
October 9, 2025
September 24, 2025
September 3, 2025
August 28, 2025
May 7, 2025
April 24, 2025
April 8, 2025
January 8, 2025
January 29, 2026
Fidēs unites deep medical expertise with a flexible suite of tools to streamline imaging processes, helping sponsors answer hard questions earlier in ...
January 27, 2026
Epigenica AB announces the launch of its EpiFinder™ Analysis Service, a fully managed, high-throughput platform designed to make advanced epigenomic r...
January 26, 2026
Ceryx has strengthened its Board of Directors with the appointment of Mark Strong, a highly respected medical devices executive with decades of global...
Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225